@article{c07eb67716f3440fb8e06d9fbcaf1fd7,
title = "Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma",
author = "Charlotte Rigaud and Samuel Abbou and V{\'e}ronique Minard-Colin and Birgit Geoerger and Scoazec, {Jean Yves} and Gilles Vassal and Nabaz Jaff and Laurence Heuberger and Dominique Valteau-Couanet and Laurence Brugieres",
note = "Funding Information: S.A. and B.G. report receiving honoraria for consulting from Bristol-Myers Squibb. V.M. reports research funding from Roche and Bristol-Myers Squibb. G.V. reports being the main investigator of the AcS{\'e} crizotinib trial and Advisory consultant to Bristol Myer Squibb without personal remuneration. L.B. reports being member of an advisory board for Takeda without personal remuneration. The other authors declare no competing interests.",
year = "2018",
month = apr,
day = "1",
doi = "10.1002/pbc.26902",
language = "English",
volume = "65",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
number = "4",
}